Transition Therapeutics raises $11m to fund 3 studies
This article was originally published in Scrip
Executive Summary
Canadian firm Transition Therapeutics has closed a private placement of 2.6 million units of shares and warrants, raising $11m which the company will use to complete three Phase II studies.